Visual and anatomical outcome following submacular surgery for @entity1940 secondary to XXXX .

@entity1 @entity227 @entity295 @entity1940 @entity82 @entity2295 @entity281 @entity941 @entity3225
PURPOSE: To report the long-term visual and anatomical outcomes for @entity1 treated with submacular surgery for @entity1940 associated with endogenous @entity3225 . METHODS: Review of the medical records, @entity941 angiograms, fundus photographs, and histopathologic specimens of @entity1 treated with submacular surgery for @entity1940 following @entity3225 . RESULTS: This series included 3 @entity1 (1 @entity1 and 2 @entity1 ) who were 26, 30, and 60 years of age. Each @entity1 had received systemic antifungal treatment for culture-proven @entity295 before the development of @entity1940 . Each @entity1 had bilateral @entity1940 diagnosed by biomicroscopic examination and angiographic appearance: 2 eyes had an active subfoveal membrane; 2, an active juxtafoveal subretinal membrane; and 2, a mixture of active @entity2295 with subfoveal @entity82 . Submacular surgery was performed on five eyes with @entity1940 ; one eye with subfoveal @entity82 was observed. Visual acuity improved substantially in 4 eyes of 3 @entity1 treated with submacular surgery. Visual improvement was limited in the two eyes with preexisting submacular @entity82 . During 13-month to 82-month follow-ups, vision remained stable, with no recurrence of @entity2295 . CONCLUSION: @entity1940 can cause severe @entity227 in @entity1 with endogenous @entity281 . Submacular surgery with removal of @entity1940 may restore vision in selected @entity1 . Subfoveal @entity82 may limit visual improvement.
